Superfluous Mammography Prevalent Prior to Breast Reduction
|
By HospiMedica International staff writers Posted on 21 Feb 2019 |
|
A new study reveals that nearly one-third of young women underwent mammography before cosmetic breast reduction surgery, despite the fact that no professional society recommends routine screening before age 40.
Researchers at Michigan Medicine (Ann Arbor, USA), the Veterans Affairs Center for Clinical Management Research (Ann Arbor, MI, USA), and other institutions searched the records of 52,486 women being evaluated for reduction mammoplasty between 2009 and 2015. The researchers excluded from the analysis women whose medical records indicated a personal or family history of breast cancer, genetic predisposition, or prior benign breast disease.
The results revealed that 30% of women 30-39 years of age had mammograms before breast reduction surgery, a rate five times higher than that of other women their age. Among these, 14% went on to have magnetic resonance imaging (MRI), ultrasonography, or a biopsy. Cancer was found in only 0.5% of the women. In addition, 4% of women 29 and younger received a mammogram before breast reduction, compared with just 0.2% of the population of millennial women. The study was published on December 26, 2018, in JAMA Surgery.
“Altering screening mammography for patients younger than 40 years in the setting of evaluation for breast surgery has a risk for subsequent tests and invasive procedures,” said lead author Erica Sears, MD, of Michigan Medicine. “I think that if there’s more awareness among patients, they may be motivated to have a conversation with their doctor about whether screening mammography is right for them. It’s also about education on the provider’s part about the downstream impact of future testing that women may experience.”
The American Society of Plastic Surgeons, among other organizations, recommended in 2014 that women undergoing elective breast surgery should not receive routine preoperative mammography beyond existing guidelines recommendations, considering risk factors and age, unless a specific concern exists based on their medical history or a physical finding.
Related Links:
Michigan Medicine
Veterans Affairs Center for Clinical Management Research
Researchers at Michigan Medicine (Ann Arbor, USA), the Veterans Affairs Center for Clinical Management Research (Ann Arbor, MI, USA), and other institutions searched the records of 52,486 women being evaluated for reduction mammoplasty between 2009 and 2015. The researchers excluded from the analysis women whose medical records indicated a personal or family history of breast cancer, genetic predisposition, or prior benign breast disease.
The results revealed that 30% of women 30-39 years of age had mammograms before breast reduction surgery, a rate five times higher than that of other women their age. Among these, 14% went on to have magnetic resonance imaging (MRI), ultrasonography, or a biopsy. Cancer was found in only 0.5% of the women. In addition, 4% of women 29 and younger received a mammogram before breast reduction, compared with just 0.2% of the population of millennial women. The study was published on December 26, 2018, in JAMA Surgery.
“Altering screening mammography for patients younger than 40 years in the setting of evaluation for breast surgery has a risk for subsequent tests and invasive procedures,” said lead author Erica Sears, MD, of Michigan Medicine. “I think that if there’s more awareness among patients, they may be motivated to have a conversation with their doctor about whether screening mammography is right for them. It’s also about education on the provider’s part about the downstream impact of future testing that women may experience.”
The American Society of Plastic Surgeons, among other organizations, recommended in 2014 that women undergoing elective breast surgery should not receive routine preoperative mammography beyond existing guidelines recommendations, considering risk factors and age, unless a specific concern exists based on their medical history or a physical finding.
Related Links:
Michigan Medicine
Veterans Affairs Center for Clinical Management Research
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Rapid Sepsis Test
SeptiCyte RAPID
New
Surgical System
Stealth AXiS
Latest General/Advanced Imaging News
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read more
Critical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read more
Surgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
